Curaleaf Celebrates President Trump's Landmark Rescheduling of Cannabis Under Controlled Substances Act
Rhea-AI Summary
Curaleaf (OTCQX: CURLF) applauded the Trump Administration's December 18, 2025 rescheduling of cannabis to Schedule III under the Controlled Substances Act.
The company said the reclassification should enable federally funded clinical research, expand patient access, support veterans, remove onerous tax penalties, and create opportunities for investment, jobs, and local tax revenue. Curaleaf's chairman and CEO praised the move as aligning federal policy with scientific understanding and widespread public support.
Positive
- Federal rescheduling to Schedule III for cannabis
- Opens pathway for federally funded clinical research
- Removes certain onerous tax penalties cited in the release
- Creates potential for expanded investment, jobs, and tax revenue
Negative
- None.
News Market Reaction – CURLF
In the Dec 18 session, CURLF declined 32.04%, reflecting a significant negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Trump Administration's Rescheduling Opens New Avenues for Research, Medical Advancement, and Investment
"Curaleaf thanks President Trump for acting on his commitment to move forward with cannabis reclassification and we express our deep gratitude to him for this bold move," said Boris Jordan, Chairman and CEO of Curaleaf. "Moving the plant from Schedule I to Schedule III acknowledges what has been known for thousands of years, that the cannabis plant has medicinal properties. This policy shift by
Rescheduling cannabis to Schedule III is a meaningful step toward destigmatizing the plant by opening avenues to federally funded clinical research, supporting veterans, expanding patient access, and more. It also eliminates onerous tax penalties and creates opportunities for expanded investment into state programs that will create jobs and tax revenue for local communities.
"Under President Trump's leadership,"
The reclassification of cannabis aligns with nearly nine-in-ten
About Curaleaf Holdings
Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf") is a leading international provider of consumer products in cannabis with a mission to enhance lives by cultivating, sharing and celebrating the power of the plant. As a high-growth cannabis company known for quality, expertise and reliability, the Company and its brands, including Curaleaf, Select, Grassroots, Find, Anthem, and The Hemp Company provide industry-leading service, product selection and accessibility across the medical and adult use markets. Curaleaf International is powered by a strong presence in all stages of the supply chain. Its distribution network throughout
Forward Looking Statements
This media advisory contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward–looking statements or information. Generally, forward-looking statements and information may be identified by the use of forward-looking terminology such as "plans", "expects" or "proposed", "is expected", "intends", "anticipates", or "believes", or variations of such words and phrases, or by the use of words or phrases which state that certain actions, events or results may, could, would, or might occur or be achieved. More particularly and without limitation, this news release contains forward-looking statements and information concerning the federal rescheduling of cannabis. Such forward-looking statements and information reflect management's current beliefs and are based on assumptions made by and information currently available to the company with respect to the matter described in this new release. Forward-looking statements involve risks and uncertainties, which are based on current expectations as of the date of this release and subject to known and unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Additional information about these assumptions and uncertainties is contained under "Risk Factors and Uncertainties" in the Company's latest annual information form filed on March 3, 2025, which is available under the Company's SEDAR profile at http://www.sedar.com, and in other filings that the Company has made and may make with applicable securities authorities in the future. Forward-looking statements contained herein are made only as to the date of this press release and we undertake no obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as required by law. We caution investors not to place considerable reliance on the forward-looking statements contained in this press release. The Toronto Stock Exchange has not reviewed, approved or disapproved the content of this news release.
Investor Contact:
Curaleaf Holdings, Inc.
Camilo Lyon, Chief Investment Officer
IR@curaleaf.com
Media Contact:
MATTIO Communications
MattioCuraleaf@Mattio.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/curaleaf-celebrates-president-trumps-landmark-rescheduling-of-cannabis-under-controlled-substances-act-302646326.html
SOURCE Curaleaf Holdings, Inc.